Philosophy of Care
Dr. Sageshima believes that optimizing organ recovery, preservation and transplant surgery, provides more opportunities of transplantation to patients with end-stage organ disease.
Dr. Sageshima's clinical interests include: adult and pediatric kidney and pancreas transplant surgery, organ recovery and preservation, live donor surgery, vascular access surgery, and minimally invasive surgery.
Dr. Sageshima's research interests include: clinical kidney and pancreas transplantation (adult and pediatric), organ recovery and preservation, clinical outcome research, and translational research.
M.D., Showa University School of Medicine, Shinagawa, Tokyo, Japan
Surgery, Tokyo Women's Medical College Hospital, Tokyo, Japan, 1996
Transplant Surgery, University of Miami/Jackson Memorial Hospital, Miami, FL, 2004
Japan Surgical Society, 2013
American College of Surgeons
American Society of Transplant Surgeons
International Pancreas and Islet Transplant Association
The International Society for Organ Donation and Procurement
The Japan Surgical Society
The Transplantation Society
Select Recent Publications
Sageshima J, Ciancio G, Chen L, Dohi T, El-Hinnawi A, Paloyo S, Misawa R, Ekwenna O, Yatawatta A, Burke GW 3rd. Everolimus with Low-Dose Tacrolimus in Simultaneous Pancreas and Kidney Transplantation. Clin Transplant. 2014 [Epub ahead of print]
Sageshima J, Ciancio G, Chen L, Dohi T, El-Hinnawi A, Paloyo S, Gaynor JJ, Mattiazzi A, Guerra G, Kupin W, Roth D, Ruiz P, Burke GW, 3rd. Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy. Transpl Immunol. 2014; 30(2-3):88.
Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW, 3rd, Mundel P. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013; 369(25):2416.
Ciancio G, Sageshima J, Akpinar E, Gaynor JJ, Chen L, Zarak A, Hanson L, Tueros L, Guerra G, Mattiazzi A, Kupin W, Roth D, Ricordi C, Burke GW, 3rd. A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. Transplantation. 2013; 96(9):800.
Ciancio G, Sageshima J, Chen L, Gaynor JJ, Hanson L, Tueros L, Velarde EM, Gomez C, Kupin W, Guerra G, Mattiazzi A, Fornoni A, Pugliese A, Roth D, Wolf M, Burke Iii GW. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. Am J Transplant. 2012; 12(12):3363.
Hibi T, Sageshima J, Molina E, Ciancio G, Nishida S, Chen L, Arosemena L, Mattiazzi A, Guerra G, Kupin W, Tekin A, Selvaggi G, Levi D, Ruiz P, Livingstone AS, Roth D, Martin P, Tzakis A, Burke GW. Predisposing Factors of Diminished Survival in Simultaneous Liver/Kidney Transplantation. Am J Transplant. 2012; 12(11):2966.
Ciancio G, Gaynor JJ, Sageshima J, Roth D, Kupin W, Guerra G, Tueros L, Zarak A, Hanson L, Ganz S, Chen L, Ruiz P, Livingstone AS, Burke GW, 3rd. Machine perfusion following static cold storage preservation in kidney transplantation: donor-matched pair analysis of the prognostic impact of longer pump time. Transpl Int. 2012; 25(1):34.
Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011; 17(8):952.
Sageshima J, Ciancio G, Guerra G, Gaynor JJ, Cova D, Zarak A, Chen L, Mattiazzi A, Kupin W, Roth D, Hanson L, Livingstone AS, Ruiz P, Burke GW. Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation. Transpl Immunol. 2011; 25(2-3):104.
Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW, 3rd. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011; 3(85):85ra46.